Development Pipelines
Pipelines
Status
EF-001 (Cerebraca® Wafer)
EF-009 Wafer
HK-001
EF-031
EF-001 (Cerebraca® Wafer)
- IND application approved by USFDA and TFDA
- Orphan drug Designation (USFDA)
- A phase 1/2a clinical trial in Taiwan is ongoing (Completed a phase 1 clinical trial)
EF-009 Wafer
- IND application approved by USFDA and TFDA
HK-001
- IND application approved by USFDA and TFDA
- A phase 1 clinical trial in Taiwan is ongoing
EF-031
- Pre-clinical studies
- Prepared for IND application
Partnering and Collaboration
EFB is looking for the opportunity to cooperate with international pharmaceutical companies or venture capitals.
Please mail us on efbiotech@efbiotech.com
Partner
